NALFX
Price
$73.30
Change
+$0.54 (+0.74%)
Updated
Sep 5 closing price
Net Assets
264.73M
RSLFX
Price
$79.22
Change
+$0.57 (+0.72%)
Updated
Sep 5 closing price
Net Assets
80.82B
Interact to see
Advertisement

NALFX vs RSLFX

Header iconNALFX vs RSLFX Comparison
Open Charts NALFX vs RSLFXBanner chart's image
New Alternatives A
Price$73.30
Change+$0.54 (+0.74%)
VolumeN/A
Net Assets264.73M
American Funds SMALLCAP World R5
Price$79.22
Change+$0.57 (+0.72%)
VolumeN/A
Net Assets80.82B
NALFX vs RSLFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NALFX vs. RSLFX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NALFX is a Buy and RSLFX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLFX has more cash in the bank: 80.8B vs. NALFX (265M). NALFX pays higher dividends than RSLFX: NALFX (1.68) vs RSLFX (0.83). NALFX was incepted earlier than RSLFX: NALFX (43 years) vs RSLFX (23 years). NALFX (1.03) is less costly to investors than RSLFX (0.70). RSLFX is a more actively managed with annual turnover of: 32.00 vs. NALFX (5.94). RSLFX has a lower initial minimum investment than NALFX: RSLFX (250) vs NALFX (2500). RSLFX annual gain was more profitable for investors over the last year : 12.70 vs. NALFX (10.16). RSLFX return over 5 years is better than : 20.11 vs. NALFX (8.11).
NALFXRSLFXNALFX / RSLFX
Total Expense Ratio1.030.70147%
Annual Report Gross Expense Ratio1.030.70147%
Fund Existence43 years23 years-
Gain YTD20.79811.946174%
Front Load4%N/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets265M80.8B0%
Annual Yield % from dividends1.680.83202%
Returns for 1 year10.1612.7080%
Returns for 3 years-1.4737.83-4%
Returns for 5 years8.1120.1140%
Returns for 10 years93.9368.11138%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTNM11.500.51
+4.64%
Contineum Therapeutics
CAVA66.630.67
+1.02%
CAVA Group
BEDU1.70N/A
N/A
Bright Scholar Education Holdings Limited
OXLCO23.32-0.07
-0.28%
Oxford Lane Capital Corp
GABC41.29-0.44
-1.05%
German American Bancorp